CAS: 869939-83-3 - (δS)-δ-Amino-4-[[4-[[[2,4-dichloro-3-[[(2,4-dimethyl-8-quinolinyl)oxy]methyl]phenyl]sulfonyl]amino]tetrahydro-2H-pyran-4-yl]carbonyl]-N,N,N-trimethyl-ε-oxo-1-piperazinepentanaminium
Fórmula:C36H49Cl2N6O6S
InChI:InChI=1S/C36H49Cl2N6O6S/c1-24-22-25(2)40-33-26(24)8-6-10-30(33)50-23-27-28(37)11-12-31(32(27)38)51(47,48)41-36(13-20-49-21-14-36)35(46)43-17-15-42(16-18-43)34(45)29(39)9-7-19-44(3,4)5/h6,8,10-12,22,29,41H,7,9,13-21,23,39H2,1-5H3/q+1/t29-/m0/s1
Clave InChI:InChIKey=FQVSDHOWSLEEKJ-LJAQVGFWSA-N
SMILES:O=C(N1CCN(C(=O)C2(NS(=O)(=O)C3=CC=C(Cl)C(=C3Cl)COC4=CC=CC5=C4N=C(C=C5C)C)CCOCC2)CC1)C(N)CCC[N+](C)(C)C
- Sinónimos:
- 1-Piperazinepentanaminium, δ-amino-4-[[4-[[[2,4-dichloro-3-[[(2,4-dimethyl-8-quinolinyl)oxy]methyl]phenyl]sulfonyl]amino]tetrahydro-2H-pyran-4-yl]carbonyl]-N,N,N-trimethyl-ε-oxo-, (δS)-
- (δS)-δ-Amino-4-[[4-[[[2,4-dichloro-3-[[(2,4-dimethyl-8-quinolinyl)oxy]methyl]phenyl]sulfonyl]amino]tetrahydro-2H-pyran-4-yl]carbonyl]-N,N,N-trimethyl-ε-oxo-1-piperazinepentanaminium
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
Fasitibant REF: TR-F869860CAS: 869939-83-3 | - - - | 13.318,00 € | Mar 21 Ene 25 | |
Fasitibant REF: 3D-UJB93983CAS: 869939-83-3 | Min. 95% | A consultar | Mar 21 Ene 25 | |
Fasitibant REF: TM-T68486CAS: 869939-83-3 | - - - | 2.396,00 €~4.289,00 € | Mar 11 Mar 25 |
Fasitibant
Producto controladoRef: TR-F869860
100mg | 13.318,00 € |
Fasitibant
Ref: 3D-UJB93983
5mg | A consultar | ||
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar |
Fasitibant
Ref: TM-T68486
25mg | 2.396,00 € | ||
50mg | 3.152,00 € | ||
100mg | 4.289,00 € |